These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 9410067)

  • 21. Tissue penetration of Meropenem in patients undergoing gynecologic surgery.
    Gall S; Hemsell DL; McGregor JA; Martens MG; Pitkin D; Allen S
    Clin Infect Dis; 1997 Feb; 24 Suppl 2():S178-80. PubMed ID: 9126690
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Population pharmacokinetics of meropenem during continuous infusion in surgical ICU patients.
    Kees MG; Minichmayr IK; Moritz S; Beck S; Wicha SG; Kees F; Kloft C; Steinke T
    J Clin Pharmacol; 2016 Mar; 56(3):307-15. PubMed ID: 26222202
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Steady-state pharmacokinetics and pharmacodynamics of meropenem in hospitalized patients.
    Cheatham SC; Kays MB; Smith DW; Wack MF; Sowinski KM
    Pharmacotherapy; 2008 Jun; 28(6):691-8. PubMed ID: 18503396
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of Meropenem Penetration into Cerebrospinal Fluid in Patients with Meningitis After Neurosurgery.
    Zhang Y; Zhang J; Chen Y; Yu J; Cao G; Wu X; Chen M; Wu J; Zhao X
    World Neurosurg; 2017 Feb; 98():525-531. PubMed ID: 27867128
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparison of the pharmacokinetics of meropenem after administration by intravenous injection over 5 min and intravenous infusion over 30 min.
    Kelly HC; Hutchison M; Haworth SJ
    J Antimicrob Chemother; 1995 Jul; 36 Suppl A():35-41. PubMed ID: 8543497
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacodynamic modeling of beta-lactam antibiotics for the empiric treatment of secondary peritonitis: a report from the OPTAMA program.
    Kotapati S; Kuti JL; Nicolau DP
    Surg Infect (Larchmt); 2005; 6(3):297-304. PubMed ID: 16201939
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetic and pharmacodynamic properties of meropenem.
    Nicolau DP
    Clin Infect Dis; 2008 Sep; 47 Suppl 1():S32-40. PubMed ID: 18713048
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A compilation of meropenem tissue distribution data.
    Hutchison M; Faulkner KL; Turner PJ; Haworth SJ; Sheikh W; Nadler H; Pitkin DH
    J Antimicrob Chemother; 1995 Jul; 36 Suppl A():43-56. PubMed ID: 8543498
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics of meropenem in critically ill patients with acute renal failure undergoing continuous venovenous hemofiltration.
    Tegeder I; Neumann F; Bremer F; Brune K; Lötsch J; Geisslinger G
    Clin Pharmacol Ther; 1999 Jan; 65(1):50-7. PubMed ID: 9951430
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics of meropenem in patients with various degrees of renal function, including patients with end-stage renal disease.
    Chimata M; Nagase M; Suzuki Y; Shimomura M; Kakuta S
    Antimicrob Agents Chemother; 1993 Feb; 37(2):229-33. PubMed ID: 8452352
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Fundamental and clinical studies of imipenem/cilastatin sodium in the field of obstetrics and gynecology. Study group of imipenem/cilastatin sodium in the field of obstetric and gynecological infections].
    Matsuda S; Suzuki M; Hasegawa Y; Ninomiya K; Shimizu T; Maeda Y; Ichinoe K; Makinoda S; Sato H; Sato H
    Jpn J Antibiot; 1986 Jun; 39(6):1626-55. PubMed ID: 3531568
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Single-dose pharmacokinetics of imipenem-cilastatin in pediatric patients.
    Engelhard D; Shalit I; Stutman HR; Greenwood R; Griffis J; Marks MI
    Pediatr Pharmacol (New York); 1986; 5(4):273-9. PubMed ID: 3461422
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dosing optimization of meropenem based on a pharmacokinetic analysis in patients receiving hemodiafiltration and an in vitro model.
    Yokoyama Y; Nishino K; Matsumoto K; Inomoto Y; Matsuda K; Nakamura RN; Yasuno N; Kizu J
    J Infect Chemother; 2018 Feb; 24(2):92-98. PubMed ID: 29054458
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Imipenem-Relebactam and Meropenem-Vaborbactam: Two Novel Carbapenem-β-Lactamase Inhibitor Combinations.
    Zhanel GG; Lawrence CK; Adam H; Schweizer F; Zelenitsky S; Zhanel M; Lagacé-Wiens PRS; Walkty A; Denisuik A; Golden A; Gin AS; Hoban DJ; Lynch JP; Karlowsky JA
    Drugs; 2018 Jan; 78(1):65-98. PubMed ID: 29230684
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics of meropenem in patients with renal failure and patients receiving renal replacement therapy.
    Thalhammer F; Hörl WH
    Clin Pharmacokinet; 2000 Oct; 39(4):271-9. PubMed ID: 11069213
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics and pharmacodynamics of meropenem in children with severe infection.
    Kongthavonsakul K; Lucksiri A; Eakanunkul S; Roongjang S; Issaranggoon Na Ayuthaya S; Oberdorfer P
    Int J Antimicrob Agents; 2016 Aug; 48(2):151-7. PubMed ID: 27345269
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Optimal treatment schedule of meropenem for adult patients with febrile neutropenia based on pharmacokinetic-pharmacodynamic analysis.
    Ohata Y; Tomita Y; Nakayama M; Tamura K; Tanigawara Y
    J Infect Chemother; 2011 Dec; 17(6):831-41. PubMed ID: 21773752
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacodynamics of meropenem in critically ill patients with febrile neutropenia and bacteraemia.
    Jaruratanasirikul S; Limapichat T; Jullangkoon M; Aeinlang N; Ingviya N; Wongpoowarak W
    Int J Antimicrob Agents; 2011 Sep; 38(3):231-6. PubMed ID: 21726984
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antibacterial activity of achievable epithelial lining fluid exposures of Amikacin Inhale with or without meropenem.
    So W; Crandon JL; Hamada Y; Nicolau DP
    J Antimicrob Chemother; 2016 Feb; 71(2):428-37. PubMed ID: 26559690
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of obstetric and gynecologic infections with meropenem: comparison with imipenem/cilastatin.
    Maggioni P; Di Stefano F; Facchini V; Irato S; Mancuso S; Colombo M; Massobrio M; Melis GB; Crosignani P
    J Chemother; 1998 Apr; 10(2):114-21. PubMed ID: 9603636
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.